Huntleigh Advisors Inc. Raises Stock Position in Intuitive Surgical, Inc. $ISRG

Huntleigh Advisors Inc. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 97.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 2,152 shares of the medical equipment provider’s stock after purchasing an additional 1,061 shares during the quarter. Huntleigh Advisors Inc.’s holdings in Intuitive Surgical were worth $962,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in ISRG. SteelPeak Wealth LLC raised its holdings in shares of Intuitive Surgical by 28.7% in the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after buying an additional 9,364 shares during the last quarter. Eastover Investment Advisors LLC increased its position in Intuitive Surgical by 204.8% in the 2nd quarter. Eastover Investment Advisors LLC now owns 13,163 shares of the medical equipment provider’s stock valued at $7,153,000 after acquiring an additional 8,844 shares during the period. Amalgamated Bank raised its stake in Intuitive Surgical by 2.2% during the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after acquiring an additional 1,772 shares during the last quarter. Bessemer Group Inc. lifted its position in Intuitive Surgical by 89.3% during the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after acquiring an additional 371,806 shares during the period. Finally, Sax Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 218.1% in the 2nd quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock valued at $1,334,000 after purchasing an additional 1,684 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently commented on ISRG. Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Barclays restated an “overweight” rating and set a $686.00 price objective (up previously from $635.00) on shares of Intuitive Surgical in a research report on Wednesday, January 7th. Rothschild & Co Redburn lifted their target price on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Argus boosted their price target on shares of Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Finally, Mizuho set a $575.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $622.17.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 750 shares of the business’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $435,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the sale, the executive vice president directly owned 3,056 shares in the company, valued at $1,772,480. This trade represents a 81.80% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Down 1.4%

Shares of ISRG opened at $527.44 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The company has a 50-day simple moving average of $564.60 and a 200-day simple moving average of $511.68. The company has a market capitalization of $189.08 billion, a PE ratio of 69.77, a P/E/G ratio of 4.35 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the previous year, the firm earned $1.84 earnings per share. The firm’s revenue was up 22.9% on a year-over-year basis. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.